Paper Details

  1. Home
  2. Paper Details

Long-term follow-up of patients with birdshot retinochoroidopathy treated with systemic immunosuppression.

Author: BeckerMatthias D, RosenbaumJames T, SmithJustine R, WertheimMichael S

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).

Overview

Birdshot retinochoroidopathy (BRC) is a rare uveitis syndrome. Systemic and periocular corticosteroids are of inconsistent efficacy, and corticosteroid-sparing strategies with agents such as cyclosporine A or azathioprine have been suggested.
Paper Details　
Original Abstract of the Article :
Birdshot retinochoroidopathy (BRC) is a rare uveitis syndrome of presumed autoimmune etiology. Therapy with systemic and periocular corticosteroids is of inconsistent efficacy, attendant with numerous potential long-term side effects. Corticosteroid-sparing strategies with agents such as cyclosporin...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/09273940490912407

データ提供：米国国立医学図書館（NLM）

Birdshot Retinochoroidopathy: A Desert of Inflammation in the Eye

Birdshot retinochoroidopathy (BRC) is a rare eye disease characterized by inflammation of the retina and choroid. This study investigates the long-term outcomes of patients with BRC treated with systemic immunosuppression.

The researchers observed inconsistent efficacy of conventional therapies, such as systemic and periocular corticosteroids, highlighting the need for alternative approaches. They propose corticosteroid-sparing strategies utilizing agents like cyclosporine A or azathioprine to manage BRC.

A Camel's Oasis of Management

The study's findings underscore the importance of exploring alternative treatments for BRC, particularly those that minimize corticosteroid reliance. This research provides valuable insights for clinicians managing this challenging condition.

A Camel's Compass for Eye Health

This study emphasizes the importance of ongoing research to develop more effective and safe treatments for BRC. Early detection and prompt referral to a specialist are crucial for managing this complex eye disease.

Dr. Camel's Conclusion

This study highlights the need for a deeper understanding of BRC and explores alternative treatment options. The research emphasizes the importance of finding effective corticosteroid-sparing strategies to manage this complex eye disease.

Date :
  1. Date Completed 2005-10-20
  2. Date Revised 2021-12-03
Further Info :

Pubmed ID

16159719

DOI: Digital Object Identifier

10.1080/09273940490912407

Related Literature

Article Analysis
・Side Effects of mycophenolate injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.